Fierce Foundry’s Post

👩⚕️ 💪 🌷 Daily Dose of Health Insights August 4 👩⚕️ 💪 🌷 🔹 Today's Highlight: New incubator supercharging women-focused health startups in Canada "Rachel Bartholomew, CEO of Hyivy Health, faced outright disbelief when pitching her groundbreaking vaginal dilator, “Floora,” a device that combines auto-dilation and heat therapy to revolutionize pelvic floor health. Despite its innovative design, investors often dismissed her pitch, reflecting a wider issue in the field of women's health. Women-led startups, particularly in Femtech, face daunting funding hurdles. Only 4% of Canadian venture capital and even less in the U.S. and Europe supports women-founded ventures. To combat this, Bartholomew launched Femtech Canada, a powerful network of over 120 companies dedicated to women's health. The market potential for conditions like endometriosis, which impacts millions, is staggering—up to $250 billion globally. Yet, funding lags far behind conditions like erectile dysfunction. Bartholomew fights to shift the narrative and push for recognition of the crucial, often overlooked, economic and health impacts of women’s health issues. Dr. Joss Reimer from the CMA highlights the ongoing struggle for gender equity in healthcare, reminding us that women's health research was only mandated in the 1990s. Bartholomew’s work is a crucial step toward balancing this inequity." 🔎 Why Stay Updated? In the rapidly evolving field of healthcare, staying informed is crucial. Whether it's groundbreaking research, policy changes, local health events, or wellness tips, these updates are designed to enhance your understanding and keep you at the forefront of medical knowledge. 👩⚕️ Our Commitment to Community Health: At Terra Nova Medical Clinics, we believe in empowering our community with information. Knowledge is not just power; it's health. By sharing these updates, we hope to foster a well-informed community that is proactive about health and wellness. 📲 Join the Conversation: We encourage you to engage with our posts, share your thoughts, and spread awareness. Let's create a healthier, more informed community together. #TerraNovaMedical #RichmondBC #HealthCanada #FamilyPractice #StayInformed https://lnkd.in/gdpeH7NX

Flo Health responds to viral male-founded femtech funding debate - Digital Health #FloHealthResponds Flo Health, a femtech company, addresses the viral debate surrounding male-founded femtech funding. The company's response sheds light on the challenges and opportunities faced by female-led healthcare technology startups in securing funding. #GenderBiasInFemtech The blog post discusses the issue of gender bias in the femtech industry, particularly in relation to funding for female-founded companies. Flo Health's response highlights the importance of addressing this bias and promoting diversity in the healthcare IT sector. #ChallengesForFemaleFounders Female founders in the healthcare IT industry face unique challenges when seeking funding for their startups. Flo Health's perspective on these challenges provides valuable insights into the barriers that women entrepreneurs encounter in the male-dominated tech investment landscape ai.mediformatica.com #health #funding #invest #femtech #investment #investors #about #digital #digitalhealth #femalefounders #flohealth #unicorn #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4cfnppq)

Great to see increased focus on Women's Health needs! Closing #Womenshealth gap presents an opportunity to improve lives of half of the world's population (and resulting in benefits for everyone through improved economies). The challenge is complex, requiring a multi-faceted approach to driving innovation. This is why UNSW Founders The George Institute for Global Health Virtus Health and Australian Medical Angels launched a tailored Women's Health Accelerator program on #Health10x platform, bringing #femtech startups, clinicians, academics, industry and investors together to accelerate commercialisation. And this is why UNSW Founders are running #NewWave - a dedicate entrepreneurship program for women, to empower them with skills and networks to drive change. Applications are open for both programs, join if you want to be a part of the solution! Victoria-Rose Tucker Kristen Phillips Pallavi Ramishetty Hannah Gandevia Dr Parisa Glass Gabriella Nunes Eléonore Cluzel Joseph W. Po, PhD Cydonie Greenaway Lisa Fedorenko Vinayak Smith Reshma Gupta Dr Amandeep Hansra Dr Mian Bi

🚀 Wellbeing of Women has partnered with Maroon Invest Global to launch AstraWell, an initiative aimed at advancing women’s health. The multi-year partnership will focus on accelerating innovation and venture development in women’s health, deploying capital to fund women’s health innovation, and strengthening research and development (R&D) innovation consortiums and commercial venture platforms in the UK, the US, and globally. 💬 "Through our partnership with Wellbeing of Women, Maroon aims to significantly advance research and innovation in women’s health. This initiative will help scale commercial launches in the US and UK and address critical health issues that go beyond reproductive and sexual health, including chronic conditions like diabetes, autoimmune diseases, and neurological disorders." Lisa Lambie, Maroon Invest Global Managing Partner #femtech #womenshealth #womenshealthinnovation #health #healthcare #healthtech #healthcareinnovation #venturestudio #startupstudio #launch #partnership #unitedstates #uk #investor #vc #venturecapital #internationalization

New year, new milestones! 🎉 We’re starting 2024 on a high note with Biorithm's recent US$3.5 million Series A raise, co-led by SEEDS Capital alongside Adaptive Capital Partners. The funds will propel the company’s expansion into Southeast Asia and the United States while supporting research to expand Biorithm's product offerings. ✈️ Founded in 2014, the medical technology startup uses predictive and precision medical technology to prevent pregnancy complications and stillbirths. Their solution, FeMom, integrates digital health, advanced sensors, and data science for remote obstetric monitoring, offering clinicians insights into maternal and fetal health while providing expecting mothers convenient access to healthcare and pregnancy information. Having successfully completed clinical trials with healthcare institutions in Singapore and the UK, Biorithm is set to broaden its clinical trial reach to other markets such as the US. 🩺 “We are excited to continue backing Biorithm as they accelerate their commercialisation in the US and support their vision of revolutionising the global maternal health market,” said Kaixin Tan, general manager of Seeds Capital. #funding #venturecapital #startup #fundraising #biomedical #healthcare #medtech

Exciting developments are taking place in the healthcare industry at an unprecedented pace. However, the risks associated with speed cannot be ignored, especially when it comes to equitable and optimal decision-making. That's why it's crucial to empower healthtech startups with the necessary tools to implement 'equitable innovations' in every aspect of their work. Recently, I had the privilege of serving as a JDEI Expert for Nucleate Los Angeles' latest cohort of startups. It was an honor to advise these startups on the nuances of building a successful and equitable business. From innovative therapies for early Alzheimer's and Dementia treatment to precise drug delivery for individuals with kidney disease, these startups are tackling problems that touch all of our lives. We talked about the 'how' of equitable innovation and its importance, particularly in patient engagement and communications. If this resonates with you, register for our FREE upcoming workshop! Save your seat here: https://lnkd.in/gSfMDx-H #healthcare #innovation #healthtech #startups #equitableinnovations #research #drugdelivery #Alzheimers #Dementia #kidneydisease

Only one week left to apply to the equity free Tech4Eva - The global Femtech accelerator acceleration program 🚀 Are you a start-up passionate about enhancing women's health? Seize the opportunity to elevate your innovation and gain visibility 🌟. This program is your gateway to international scaling, offering: - Integration into a leading healthcare ecosystem in Europe 🇪🇺. - Business model refinement and strategic market entry planning 📈. - Customized coaching and expert-led workshops 📚. - Opportunities to develop pilot projects with Group Mutuel or partners 🤝. - Access to potential global customers through strategic collaborations 🌍. - Visibility & Exposure to international investors for funding opportunities💼. - Unique insights from the perspective of healthcare payers 💡. - A workspace at La Forge, EPFL Innovation Park's incubator in Lausanne 🏢. - Direct feedback from EPFL's technology experts and university networks 👩🏫. Don't miss this chance to be a part of the strong global Tech4Eva community and join the 4th cohort 💪. Apply now to embark on a journey of growth, impact, and global networking: https://hubs.li/Q02nvMBb0 Check out our mentors and experts here: https://hubs.li/Q02nvPkx0 Partners: EPFL Innovation Park, Groupe Mutuel, Amboy Street Ventures, Business Angels Switzerland, CSEM, DayOne - Healthcare Innovation Embassy of Switzerland in London, Essity, Femtech France, FemTech Analytics, fermata, Inc., INSEAD Healthcare Club, Joyance Partners, RH Capital, Rhia Ventures, SICTIC, Swiss Biotech Association, Swissnex in Boston and New York, Women of Wearables (wearables, health tech & femtech) #Tech4Eva #EPFLInnovationPark #GroupeMutuel #Femtech #womenshealth #periodhealth #wellbeing #fertility #pregnancy #prevention #treatment #menopause #oncology #health #innovation #entrepreneurs #womenhealthmatters #Reproductivehealth #femtech #medtech #digitalhealth #nutrition #wellbeing #prevention #wearables #apps #diagnostics #therapeutics #health #techfounders #womenshealthmatters #womenshealthcare #investments #disruptivetechnologies #founders #venturecapital #startups

MedtechWOMEN invites you to join us next week for the second episode of MedtechFORUM: Women's Health in 2024 and Beyond, moderated by Marga Ortigas-Wedekind, Chief Commercial Strategy Officer, Fogarty Innovation. The increased attention on innovations in women's health, often encapsulated under the term "FemTech," has indeed generated significant buzz in recent years. However, it's essential to critically evaluate whether the level of invention and investment has truly aligned with the unmet needs in this space. First, let's redefine "Women's Health." While reproductive health and women's cancers have received significant attention, there's a vast landscape of health issues that affect women differently or disproportionately. Diseases like cardiovascular conditions, depression, and endometriosis often go underdiagnosed or undertreated. Additionally, medical issues such as osteoporosis impact women at various stages of their lives. To truly address women's health needs, innovation must extend beyond traditional focuses. For investors in this space, raising high-quality funds using traditional venture models has been a challenge. Data is scarce, making it difficult to quantify returns, and with only 15% of women venture capitalists in decision-making roles,1 old biases still drive investment choices. The result is that FemTech represents only 2-4%2 of all health tech and biopharma investments. Join our panel of women entrepreneurs and investors as we grapple with these challenges. We'll examine the headwinds and tailwinds affecting women's health today and explore what the medtech ecosystem must do better to support the issues faced by 50% of the world's population. Together, let's pave the way for innovation that truly meets the diverse and evolving needs of women worldwide. Date: Wednesday, May 22 Time: 11:30am PT - In Person Arrival at Fogarty Innovation & Lunch 12:00-1:00pm PT - Virtual Event Begins Location: Fogarty Innovation 2495 Hospital Drive, Suite 300 Mountain View, CA Moderator: Marga Ortigas-Wedekind, Chief Commercial Strategy Officer, Fogarty Innovation Panelists: Amelia Degenkolb - CEO & Co-Founder, Novocuff, Inc. Andrea Olariu - Chief Executive Officer, Medicines360 Laura Yecies - CEO & Board Director, Bone Health Technologies Tracy Dooley MD - Partner, Avestria Ventures Cost: $20 registration fee with 50% of the proceeds from this webinar going to the Magee-Womens Research Institute & Foundation. Register to attend In Person https://lnkd.in/gPfnwe56 Register to attend Virtually https://lnkd.in/gtn2bB9a Lisa Carmel, Laurel Burk, Deborah K., Jessica Richter, Amanda DePalma, Kate J. Stephenson, PhD, Estefi Alvarez, PhD, Lynette Kozuma (she/her/hers), Endia J. C.., Ann Buckman,

MedtechWOMEN invites you to join us for the second episode of MedtechFORUM: Women's Health in 2024 and Beyond, moderated by Marga Ortigas-Wedekind, Chief Commercial Strategy Officer, Fogarty Innovation. The increased attention on innovations in women's health, often encapsulated under the term "FemTech," has indeed generated significant buzz in recent years. However, it's essential to critically evaluate whether the level of invention and investment has truly aligned with the unmet needs in this space. First, let's redefine "Women's Health." While reproductive health and women's cancers have received significant attention, there's a vast landscape of health issues that affect women differently or disproportionately. Diseases like cardiovascular conditions, depression, and endometriosis often go underdiagnosed or undertreated. Additionally, medical issues such as osteoporosis impact women at various stages of their lives. To truly address women's health needs, innovation must extend beyond traditional focuses. For investors in this space, raising high-quality funds using traditional venture models has been a challenge. Data is scarce, making it difficult to quantify returns, and with only 15% of women venture capitalists in decision-making roles,1 old biases still drive investment choices. The result is that FemTech represents only 2-4%2 of all health tech and biopharma investments. Join our panel of women entrepreneurs and investors as we grapple with these challenges. We'll examine the headwinds and tailwinds affecting women's health today and explore what the medtech ecosystem must do better to support the issues faced by 50% of the world's population. Together, let's pave the way for innovation that truly meets the diverse and evolving needs of women worldwide. Date:  Wednesday, May 22 Time: 11:30am PT - In Person Arrival at Fogarty Innovation & Lunch 12:00-1:00pm PT - Virtual Event Begins Location:  Fogarty Innovation 2495 Hospital Drive, Suite 300 Mountain View, CA Moderator: Marga Ortigas-Wedekind, Chief Commercial Strategy Officer, Fogarty Innovation Panelists: Amelia Degenkolb - CEO & Co-Founder, Novocuff, Inc. Andrea Olariu - Chief Executive Officer, Medicines360 Laura Yecies  - CEO & Board Director, Bone Health Technologies Tracy Dooley MD - Partner, Avestria Ventures Cost: $20 registration fee with 50% of the proceeds from this webinar going to the Magee-Womens Research Institute & Foundation.  Register to attend In Person  https://lnkd.in/gPfnwe56 Register to attend Virtually https://lnkd.in/gtn2bB9a Lisa Carmel, Laurel Burk, Deborah K., Jessica Richter, Amanda DePalma, Kate J. Stephenson, PhD, Estefi Alvarez, PhD, Lynette Kozuma (she/her/hers), Dr. Endia C., Ann Buckman,

🚀 Women’s health innovation faces a funding crisis. How can we change that? Despite exciting advancements, resource availability remains a major bottleneck for innovators in women’s health. Limited #funding during critical development stages forces many solutions into the "valley of death," where they fail to secure the support needed for clinical validation and commercialization. This is where new approaches can make a huge difference: 💡 Solutions: - Create a multi-billion-dollar fund aimed at bridging this gap by offering US$20-50M grants to accelerate early-stage R&D and clinical validation. Such funding can foster high-risk, high-reward research and provide women-focused startups with essential backing to develop products that address unmet needs in healthcare. - Tax incentive programs like those in Maryland and the UK can also encourage venture capitalists and angel investors to support women’s health startups. - Fund of Funds initiatives could diversify venture capital and focus on supporting female founders and underrepresented investors in the FemTech space. This strategic funding will be crucial in transforming the valley of death into a valley of birth for breakthrough innovations in women’s #health. #femtech #7mountainsmedtech Source: https://lnkd.in/g5RC6DRj